dr john eikelboom: compass' rivaroxaban plus aspirin will become standard for cad, pad
Published 7 years ago • 832 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:52
dr john eikelboom on the compass trial findings
-
1:49
dr john eikelboom on the surprising results of the compass trial
-
1:42
dr john eikelboom compares the compass trial to euclid and pegasus
-
2:46
compass rivaroxaban with aspirin for preventing stroke
-
3:23
rivaroxaban with aspirin show better cardiovascular outcomes- compass trial
-
17:26
ep:324 aspirin: yes or no? beyond generic guidelines.
-
2:42
11 wonders of caprylic acid
-
6:52
aspirin
-
4:08
compass pad - peripheral artery disease
-
2:29
dr deepak bhatt on the impact of the compass trial on standard of care
-
1:20
compass trial results
-
2:05
compass trial results how could they change cad pad treatment - daily news
-
8:01
practical implications of the compass trial in chronic cad/pad
-
1:20
compass trial: how will it change care?
-
47:58
combined antiplatelets and anticoagulants for atherosclerosis: insights from the compass study
-
2:58
compass trial overview
-
51:13
compass trial insights into aspirin and rivaroxaban combined therapy, october 13 2017
-
1:51
deepak bhatt, md: use of rivaroxaban post-compass
-
5:19
hfa 2018: compass chf -rivaroxaban plus aspirin in patients with and without heart failure
-
4:06
rivaroxaban plus aspirin cut cardiovascular events in stable patients
-
1:48:10
clinical updates in using rivaroxaban in atrial fibrillation & cad patients
-
1:32
what should pharmacists advise patients taking aspirin and rivaroxaban, if approved?